Insulin-like growth factor binding protein-3 stimulates phosphatidylinositol 3-kinase in MCF-7 breast carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 314, Issue 4, 2004, Pages 1044-1049

  Ricort, Jean Marc ^a   Binoux, Michel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CANCER CELL CULTURE; CELL STIMULATION; CELL STRAIN MCF 7; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INCUBATION TIME; INTRACELLULAR MEMBRANE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0942289892     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.001     Document Type: Article

References (35)

1. Baserga R., Prisco M., Hongo A. IGFs and cell growth. Rosenfeld R.G., Roberts C.T. Jr. The IGF System. 1999;329-353 Humana Press, Totowa, NJ.
2. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:1995;3-34.
3. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.J. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16:1995;143-163.
4. Rajah R., Lee K.W., Cohen P. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. Cell Growth Differ. 13:2002;163-171.
5. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23:2002;824-854.
6. Oh Y., Muller H.L., Pham H., Rosenfeld R.G. Demonstration of receptors for insulin-like growth factor binding protein-3 on HS578T human breast cancer cells. J. Biol. Chem. 268:1993;26045-26048.
7. Ricort J.M., Lombet A., Lassarre C., Binoux M. Insulin-like growth factor binding protein-3 increases intracellular calcium concentrations in MCF-7 breast carcinoma cells. FEBS Lett. 527:2002;293-297.
8. Valentinis B., Bhala A., DeAngelis T., Baserga R., Cohen P. The human Insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol. 9:1995;361-367.
9. Rajah R., Valentinis B., Cohen P. Insulin-like growth factor-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272:1997;12181-12188.
10. Ricort J.-M., Binoux M. Insulin-like growth factor binding protein-3 inhibits type 1 insulin-like growth factor receptor activation independently of its insulin-like growth factor binding affinity. Endocrinology. 142:2001;108-113.
11. Ricort J.-M., Binoux M. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. J. Biol. Chem. 277:2002;19448-19454.
12. Fanayan S., Firth S.M., Butt A.J., Baxter R.C. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. J. Biol. Chem. 275:2000;39146-39151.
13. Fanayan S., Firth S.M., Baxter R.C. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. J. Biol. Chem. 277:2002;7255-7261.
14. Dufourny B., Alblas J., van Teeffelen A.A.M., van Schaik F.M.A., van der Burg B., Steenbergh P.H., Sussenbach J.S. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J. Biol. Chem. 272:1997;31163-31171.
15. Roche S., Koegl M., Courtneidge S.A. The phosphatidylinositol 3-kinase α is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl. Acad. Sci. USA. 91:1994;9185-9189.
16. Magun R., Burgering B., Coffer P., Pardasani D., Lin Y., Chabot J., Sorisky A. Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology. 137:1996;3590-3593.
17. Cross D.A.E., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:1995;785-789.
18. Herman P., Emr S. Characterization of VPS34, a gene required for vacuolar protein sorting and vacuole segregation in Saccharomyces cerevisiae. Mol. Cell. Biol. 10:1990;6742-6754.
19. Yao R., Cooper G. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267:1995;2003-2006.
20. Leevers S., Vanhaesebroeck B., Waterfield M. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr. Opin. Cell Biol. 11:1999;219-225.
21. Patki V., Lawe D., Corvera S., Virbasius J., Chawla A. A functional PtdIns(3)P-binding motif. Nature. 394:1998;433-434.
22. Anderson K.E., Jackson S.P. Class I phosphoinositide 3-kinases. Int. J. Biochem. Cell Biol. 35:2003;1028-1033.
23. Giorgetti S., Ballotti R., Kowalski-Chauvel A., Cormont M., Van Obberghen E. Insulin stimulates phosphatidylinositol-3-kinase activity in rat adipocytes. Eur. J. Biochem. 207:1992;599-606.
24. Heydrick S.J., Jullien D., Gautier N., Van Obberghen E., Le Marchand-Brustel Y. Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J. Clin. Invest. 91:1993;1358-1366.
25. Leal S.M., Liu Q., Shian Huang S., San Huang J. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. J. Biol. Chem. 272:1997;20572-20576.
26. Leal S.M., Shian Huang S., San Huang J. Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-β receptor in mink lung epithelial cells. J. Biol. Chem. 274:1999;6711-6717.
27. Escobedo J.A., Navankasattusas S., Kavanaugh W.M., Milfay D., Fried V.A., Williams L.T. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor. Cell. 65:1991;75-82.
28. Yamamoto K., Altschuler D., Wood E., Horlick K., Jacobs S., Lapetina E.G. Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85. J. Biol. Chem. 267:1992;11337-11343.
29. Luttrell L.M., Daaka Y., Lefkowitz R.J. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 11:1999;177-183.
30. I. Rubio, K. Rennert, U. Wittig, R. Wetzker, Ras activation in response to lysophosphatidic acid requires a permissive input from the epidermal growth factor receptor, Biochem. J. (Pt) (2003).
31. Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D., Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 370:1994;527-532.
32. Rodriguez-Viciana P., Warne P.H., Vanhaesebroeck B., Waterfield M.D., Downward J. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 15:1996;2442-2451.
33. Backer J.M., Myers M.G., Shoelson S.E., Chin D.J., Sun X.J., Miralpeix M., Hu P., Margolis B., Skolnik E.Y., Schlessinger J., White M. Phosphatidylinositol-3-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11:1992;3469-3479.
34. Gucev Z., Oh Y., Kelley K., Rosenfeld R. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res. 56:1996;1545-1550.
35. Ching T.T., Hsu A.L., Johnson A.J., Chen C.S. Phosphoinositide 3-kinase facilitates antigen-stimulated Ca(2+) influx in RBL-2H3 mast cells via a phosphatidylinositol 3,4,5-trisphosphate-sensitive Ca(2+) entry mechanism. J. Biol. Chem. 276:2001;14814-14820.